Spain Probiotic Food Supplement Market - 2025-2028

The Spain probiotic food supplement market recorded a value of US$  95.90 million in 2024 and is expected to reach a value of US$ 131.21 million in 2028, growing at a CAGR of 8.32% during the forecast period (2025-2028).

The Spain probiotic food supplements market is experiencing steady growth, driven by increasing consumer awareness of gut health, rising demand for natural digestive solutions, and a shift toward preventive healthcare. Spanish consumers are becoming more proactive about their health, leading to higher demand for dietary supplements, including probiotics. The focus on holistic wellness and gut-brain health is encouraging consumers to incorporate probiotics into their daily routines.

Moreover, with a growing elderly population, there is an increasing demand for preventive healthcare products. For instance, By 2050, Spain's aging population is projected to exceed 36%, according to the NIH, highlighting a growing demographic shift towards an older society. Probiotic supplements are gaining traction among older adults who seek to improve digestion, boost immunity, and maintain overall health.

The increasing endorsement of probiotics by nutritionists, gastroenterologists, and pharmacists is boosting consumer confidence and encouraging adoption. As more healthcare practitioners recommend probiotics for digestive and immune health, the market is witnessing higher credibility and trust.

Drivers

Rising Prevalence of Digestive Disorders

The increasing prevalence of digestive disorders in Spain is significantly driving the demand for probiotic food supplements. Conditions such as irritable bowel syndrome (IBS), gastritis, acid reflux, bloating, and lactose intolerance are becoming more common due to factors like poor dietary habits, high consumption of processed foods, and rising stress levels.

Many Spaniards are turning to probiotic supplements as a natural and effective solution to manage these digestive issues. Probiotics help restore gut microbiota balance, reduce inflammation, and improve overall digestion, making them a preferred alternative to pharmaceutical treatments. For instance, an article published in 2024, revealed that in Spain, approximately 140,000 individuals are affected by inflammatory bowel disease, with 30–40% of these cases attributed to ulcerative colitis. The disease affects both men and women equally, with a typical age of diagnosis between 15 and 35 years.

As digestive disorders become more prevalent across different age groups, from young adults with IBS to elderly individuals with chronic gastritis, the demand for targeted probiotic solutions continues to rise. The increasing preference for preventive healthcare and natural digestive remedies positions probiotics as a crucial segment within Spain’s dietary supplement industry.

Rising Veganism and Demand for Plant-Based Probiotics

The growing adoption of veganism and plant-based diets in Spain is a major factor driving demand for plant-based probiotic food supplements. With more consumers shifting away from animal-derived products due to ethical, environmental, and health concerns, there is an increasing need for non-dairy probiotic alternatives. Many traditional probiotics are sourced from dairy-based strains such as yogurt and kefir, making them unsuitable for the rising vegan and flexitarian population. As a result, the market has responded with innovative plant-based probiotic formulations derived from sources like fermented soy, coconut, rice, and non-dairy kefir.

For instance, according to an article published in Simply Vegan, 2023, the rise of veganism in Spain appears to be ‘unchanged by the pandemic’ and has grown rapidly, with the number of vegans increasing by 60% to 315,000. While people are choosing veganism for a variety of reasons, many are excluding certain foods without expert advice, which can pose a risk to maintaining optimal health. With consumers prioritizing both health and environmental impact, plant-based probiotics have become a key growth driver in Spain’s probiotic food supplements market, encouraging brands to innovate and expand their product portfolios.

Additionally, major retailers and online platforms are expanding their plant-based probiotic offerings to cater to this shift. Carrefour and Mercadona, two of Spain’s leading supermarket chains, have introduced dairy-free probiotic drinks, capsules, and gummies, ensuring greater accessibility for vegan consumers.

Restraints

Limited Consumer Awareness of Probiotic Strains

While many Spaniards are becoming more conscious of gut health, there remains widespread confusion about which probiotic strains are effective for particular health conditions. Consumers often assume that all probiotics work the same way, leading to incorrect product choices and dissatisfaction with results. This lack of understanding discourages repeat purchases and slows market expansion.

For instance, a survey conducted by the Spanish Society of Probiotics and Prebiotics (SEPyP) found that over 40% of consumers in Spain are unaware of the differences between probiotic strains, such as Lactobacillus rhamnosus for immunity, Bifidobacterium breve for digestion, or Saccharomyces boulardii for diarrhea prevention.

Moreover, the absence of clear labeling and standardized probiotic education in retail stores and pharmacies further contributes to consumer confusion. Unlike functional foods such as yogurt, which are widely recognized for gut health, probiotic supplements require more detailed guidance. However, many Spanish pharmacies and health stores lack trained personnel to educate buyers on the benefits of different strains.

Segment Analysis

The Spain probiotic food supplement market is segmented based on ingredients, dosage, application, age, and distribution channel.

Rising Incidences of Digestive Disorders

Gut health plays a dominant role in Spain’s probiotic food supplement market, driven by rising awareness of digestive wellness and its link to overall health. Consumers are increasingly seeking probiotics to manage gut-related issues like bloating, irritable bowel syndrome (IBS), and dysbiosis. With a high prevalence of gastrointestinal disorders, including functional constipation and inflammatory bowel disease (IBD), demand for targeted probiotic solutions is growing.

Key players are developing advanced formulations, multi-strain probiotics, and functional blends targeting gut health. For instance, AB-BIOTICS, Danone Spain, Nestlé España SA, BioGaia, STADA Spain, and Procter & Gamble Spain, are key players in Spain's probiotic supplement market, focusing on gut health solutions. They offer scientifically backed probiotic formulations aimed at improving digestive health, balancing gut microbiota, and supporting immunity.

Sustainability Analysis

Spain's probiotic food supplements market is growing due to increasing consumer awareness of gut health, but sustainability challenges persist. The industry relies on dairy-based probiotics, necessitating eco-friendly sourcing and production methods. Plant-based and synbiotic formulations are emerging to reduce environmental impact. Packaging sustainability is improving with biodegradable and recyclable materials. Energy-efficient manufacturing processes and carbon footprint reduction are gaining priority.

Supply chain transparency is essential to meet EU sustainability regulations. Local ingredient sourcing is encouraged to lower emissions. Waste management strategies, including upcycling and circular economy models, are being adopted. Water usage optimization is crucial in probiotic fermentation. Ethical sourcing of bacterial strains ensures biodiversity protection. Consumer demand for clean-label, organic, and non-GMO probiotics is shaping product development.

Unmet Needs

Despite the growing adoption of probiotics, many Spanish consumers lack knowledge about specific probiotic strains and their targeted health benefits. There is a need for better consumer education, clearer labeling, and healthcare professional recommendations to guide buyers in choosing the right probiotics for digestive health, immunity, or mental well-being.

The market lacks personalized probiotic solutions tailored to individual gut microbiomes. Consumers with IBS, lactose intolerance, or antibiotic-associated gut issues require targeted formulations, but most available products offer generalized multi-strain blends without customization.

While psychobiotics (probiotics targeting mood and cognitive function) are gaining popularity in global markets, they are still underdeveloped in Spain. There is a need for clinically validated probiotics for stress reduction, anxiety management, and sleep improvement, especially as interest in gut-brain health grows. Many probiotic supplements in Spain require refrigeration or special storage conditions, making distribution and consumer usage inconvenient. There is a need for more shelf-stable probiotics using advanced microencapsulation technology to maintain potency at room temperature.

Competitive Landscape

The major players in the market include AB-BIOTICS, SA, Laboratorios Ordesa, S.L., Faes Farma S.A, TOP4U, BIOITHAS SL, DRKU (Korott), Nestlé España SA (Nestlé S.A.), BioGaia, DANONE Spain (Danone SA), Procter & Gamble Spain (Procter & Gamble), Chiesi Spain SAU (Chiesi Farmaceutici S.p.A), STADA Spain (STADA Arzneimittel AG) and others.

By Ingredient

Lactobacillus

Streptococcus

Bifidobacterium

Others

By Dosage

Tablet

Capsules

Liquid

Powder

Others

Chewables & Gummies

Soft Gels

Others

By Application

Gastrointestinal Health

Gut Microbiota/Microbiome Balance

Digestion

Constipation

Bloating

Diarrhea

Leaky Gut

Inflammation

Immune System

Others

Gluten sensitivity

Abdominal Pain

GERD/Helicobacter pylori

Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment

Gut Flora/Gut Microbiome Restoration

Others

Vaginal Health

Urinary Tract Health

Kidney Stones

UTIs

Others

Oral Health

Anti/Healthy Ageing

Allergies/Asthma

Bone & Joint Health

Osteoarthritis

Osteoporosis/Low Mineral Bone Density

Inflammation

Brain/Mental Health

Sleep

Cognition

Mood

Depression

Focus

Cardiovascular Health

Circulation

Energy/Fatigue Reduction

Metabolic Syndrome/Blood Glucose

Liver Health

Energy

Immunity/Respiratory Infections

Nutrient Absorption

Skin-Hair-Nails

Atopic Dermatitis & Eczema

Acne

Rosacea

Hair Growth/Hair Loss

Skin Microbiome

Others

Sports

Women’s Health

Fertility

Menopause

Pregnancy

Pcos

Vaginal Health & Health Vaginal Microbiome

Vaginal Infections (Bv/Vvc)

Pregnancy Outcomes

Others

Men’s Health & Men's Fertility

Weight Management

Pediatric Health

Colic

Constipation

Regurgitation

Atopic Dermatitis

Others

Others

By Age

Infant

Children

Adults

Seniors

By Distribution Channels

Supermarkets/Hypermarkets

Pharmacies and Drug Stores

Convenience Stores

Online Retailers

Other Distribution Channels

Key Developments

In December 2023, Nestlé strengthened its presence in Spain by introducing its Nestlé Health Science division at the Sebares plant in Asturias. The company invested over €7 million to establish a new production line for adult food supplements, with an annual capacity of 10,000 tonnes. This move enhances Nestlé’s nutritional health product offerings in the region.

In July 2023, Danone launched Almimama, a new science-based probiotic supplement in Spain to support breastfeeding. Backed by clinical research, Almimama contains Ligilactobacillus salivarius PS2, a patented probiotic strain that may help reduce the incidence of mastitis. This innovation reinforces Danone’s commitment to maternal health and well-being.

Why Purchase the Report?

To visualize the Spain probiotic food supplement market segmentation based on ingredient, dosage, application, age, and distribution channel, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of Spain probiotic food supplement market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The Spain probiotic food supplement report would provide approximately 51 tables, 62 figures, and 270 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Ingredient
3.2. Snippet by Dosage
3.3. Snippet by Application
3.4. Snippet by Age
3.5. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Digestive Disorders
4.1.1.2. Increasing Scientific Research and Product Innovation
4.1.2. Restraints
4.1.2.1. Limited Consumer Awareness of Probiotic Strains
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Ingredient
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
6.1.2. Market Attractiveness Index, By Ingredient
6.2. Lactobacillus*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Streptococcus
6.4. Bifidobacterium
6.5. Others
7. By Dosage
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
7.1.2. Market Attractiveness Index, By Dosage
7.2. Tablet*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Capsules
7.4. Liquid
7.5. Powder
7.6. Others
7.6.1. Chewables & Gummies
7.6.2. Soft Gels
7.6.3. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Gastrointestinal Health*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Gut Microbiota/Microbiome Balance
8.2.4. Digestion
8.2.5. Constipation
8.2.6. Bloating
8.2.7. Diarrhea
8.2.8. Leaky Gut
8.2.9. Inflammation
8.2.10. Immune System
8.2.11. Others
8.2.11.1. Gluten sensitivity
8.2.11.2. Abdominal Pain
8.2.11.3. GERD/Helicobacter pylori
8.2.11.4. Antibiotic-Associated Diarrhea/Post-Antibiotic Treatment
8.2.11.5. Gut Flora/Gut Microbiome Restoration
8.2.11.6. Others
8.3. Vaginal Health
8.4. Urinary Tract Health
8.4.1. Kidney Stones
8.4.2. UTIs
8.4.3. Others
8.5. Oral Health
8.6. Anti/Healthy Ageing
8.7. Allergies/Asthma
8.8. Bone & Joint Health
8.8.1. Osteoarthritis
8.8.2. Osteoporosis/Low Mineral Bone Density
8.8.3. Inflammation
8.9. Brain/Mental Health
8.9.1. Sleep
8.9.2. Cognition
8.9.3. Mood
8.9.4. Depression
8.9.5. Focus
8.10. Cardiovascular Health
8.11. Circulation
8.12. Energy/Fatigue Reduction
8.13. Metabolic Syndrome/Blood Glucose
8.14. Liver Health
8.15. Energy
8.16. Immunity/Respiratory Infections
8.17. Nutrient Absorption
8.18. Skin-Hair-Nails
8.18.1. Atopic Dermatitis & Eczema
8.18.2. Acne
8.18.3. Rosacea
8.18.4. Hair Growth/Hair Loss
8.18.5. Skin Microbiome
8.18.6. Others
8.19. Sports
8.20. Women’s Health
8.20.1. Fertility
8.20.2. Menopause
8.20.3. Pregnancy
8.20.4. Pcos
8.20.5. Vaginal Health & Health Vaginal Microbiome
8.20.6. Vaginal Infections (Bv/Vvc)
8.20.7. Pregnancy Outcomes
8.20.8. Others
8.21. Men’s Health & Men's Fertility
8.22. Weight Management
8.23. Pediatric Health
8.23.1. Colic
8.23.2. Constipation
8.23.3. Regurgitation
8.23.4. Atopic Dermatitis
8.23.5. Others
8.24. Others
9. By Age
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age
9.1.2. Market Attractiveness Index, By Age
9.2. Infant*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Children
9.4. Adults
9.5. Seniors
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Supermarkets/Hypermarkets*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmacies and Drug Stores
10.4. Convenience Stores
10.5. Online Retailers
10.6. Other Distribution Channels
11. Sustainability Analysis
11.1. Environmental Analysis
11.2. Economic Analysis
11.3. Governance Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. AB-BIOTICS, SA*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Laboratorios Ordesa, S.L.
13.3. Faes Farma S.A
13.4. TOP4U
13.5. BIOITHAS SL
13.6. DRKU (Korott)
13.7. Nestlé España SA (Nestlé S.A.)
13.8. BioGaia
13.9. DANONE Spain (Danone SA)
13.10. Procter & Gamble Spain (Procter & Gamble)
13.11. Chiesi Spain SAU (Chiesi Farmaceutici S.p.A)
13.12. STADA Spain (STADA Arzneimittel AG)
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings